HC Wainwright Reiterates Buy Rating for Rhythm Pharmaceuticals (NASDAQ:RYTM)
HC Wainwright reissued their buy rating on shares of Rhythm Pharmaceuticals (NASDAQ:RYTM – Free Report) in a report issued on Monday,Benzinga reports. They currently have a $69.00 price objective on the stock. Other analysts also recently issued reports about the stock. Bank of America increased their price target on shares of Rhythm Pharmaceuticals from $48.00 […]
More Stories
20,145 Shares in Advance Auto Parts, Inc. (NYSE:AAP) Acquired by Mackenzie Financial Corp
Mackenzie Financial Corp bought a new position in Advance Auto Parts, Inc. (NYSE:AAP – Free Report) during the fourth quarter,...
Insider Selling: Carvana Co. (NYSE:CVNA) CEO Sells $1,001,530.44 in Stock
Carvana Co. (NYSE:CVNA – Get Free Report) CEO Ernest C. Garcia III sold 3,086 shares of Carvana stock in a...
Sonic Automotive, Inc. (NYSE:SAH) President Jeff Dyke Sells 16,434 Shares
Sonic Automotive, Inc. (NYSE:SAH – Get Free Report) President Jeff Dyke sold 16,434 shares of Sonic Automotive stock in a...
15,958 Shares in Amprius Technologies, Inc. (NYSE:AMPX) Bought by Wolverine Trading LLC
Wolverine Trading LLC bought a new position in Amprius Technologies, Inc. (NYSE:AMPX – Free Report) in the 4th quarter, according...
79,467 Shares in ScanSource, Inc. (NASDAQ:SCSC) Purchased by Universal Beteiligungs und Servicegesellschaft mbH
Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in shares of ScanSource, Inc. (NASDAQ:SCSC – Free Report) in the...
156,781 Shares in RXO, Inc. (NYSE:RXO) Acquired by Universal Beteiligungs und Servicegesellschaft mbH
Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in shares of RXO, Inc. (NYSE:RXO – Free Report) during the...